
Sign up to save your podcasts
Or


This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.

21,968 Listeners

43,850 Listeners

32,012 Listeners

30,699 Listeners

43,592 Listeners

707 Listeners

6,409 Listeners

30,219 Listeners

125 Listeners

320 Listeners

9,904 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners